Expression and regulation of endothelin-1 and its receptors in human penile smooth muscle cells. 2002

S Granchi, and G B Vannelli, and L Vignozzi, and C Crescioli, and P Ferruzzi, and R Mancina, and M C Vinci, and G Forti, and S Filippi, and M Luconi, and F Ledda, and M Maggi
Andrology Unit, Department of Clinical Physiopathology, University of Florence, 50139 Florence, Italy.

We report for the first time that penile smooth muscle cells (SMC) not only respond to, but also synthesize, endothelin-1 (ET-1), one of the main regulators of SMC activity. Immunohistochemical studies indicated that, beside endothelial cells (EC), SMC of the human adult and fetal penis also express ET-1 and its converting enzyme, ECE-1. Accordingly, cultures of adult penile stromal cells express these genes. We also prepared and characterized penile SMC from human fetuses. These cells express SMC specific markers such as alpha smooth muscle actin and phosphodiesterase type 5A3 along with hallmarks of androgen-dependent cells (androgen receptor and 5alpha reductase type 2). Human fetal penile SMC (hfPSMC) are immunopositive for ET-1 and release ET-1. ET-1 expression in hfPSMC was strongly increased by several factors such as transforming growth factor-beta1 (TGF-beta1), interleukin-1alpha (IL-1alpha), ET-1 itself and prolonged (24 h) hypoxia. This latter condition not only affected ET-1 expression but also responsiveness. While at normal oxygen tension, hfPSMC responded to ET-1 with a decreased proliferation mediated by the endothelin-A receptors and TGF-beta1; however, during hypoxia, ET-1 stimulated cell growth. Accordingly, prolonged hypoxia up-regulated endothelin-B receptor mRNA expression. In conclusion, our results indicate that in penile tissues SMC produce ET-1 and that such production is modulated by factors involved in penile physiology and tissue remodelling. In addition, the hfPSMC we have characterized might be a useful model for studying biochemical aspects of the human erectile process in vitro.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008297 Male Males
D008666 Metalloendopeptidases ENDOPEPTIDASES which use a metal such as ZINC in the catalytic mechanism. Metallo-Endoproteinases,Metalloendopeptidase
D009130 Muscle, Smooth Unstriated and unstriped muscle, one of the muscles of the internal organs, blood vessels, hair follicles, etc. Contractile elements are elongated, usually spindle-shaped cells with centrally located nuclei. Smooth muscle fibers are bound together into sheets or bundles by reticular fibers and frequently elastic nets are also abundant. (From Stedman, 25th ed) Muscle, Involuntary,Smooth Muscle,Involuntary Muscle,Involuntary Muscles,Muscles, Involuntary,Muscles, Smooth,Smooth Muscles
D010413 Penis The external reproductive organ of males. It is composed of a mass of erectile tissue enclosed in three cylindrical fibrous compartments. Two of the three compartments, the corpus cavernosa, are placed side-by-side along the upper part of the organ. The third compartment below, the corpus spongiosum, houses the urethra. Glans Penis,Penis, Glans
D005333 Fetus The unborn young of a viviparous mammal, in the postembryonic period, after the major structures have been outlined. In humans, the unborn young from the end of the eighth week after CONCEPTION until BIRTH, as distinguished from the earlier EMBRYO, MAMMALIAN. Fetal Structures,Fetal Tissue,Fetuses,Mummified Fetus,Retained Fetus,Fetal Structure,Fetal Tissues,Fetus, Mummified,Fetus, Retained,Structure, Fetal,Structures, Fetal,Tissue, Fetal,Tissues, Fetal
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000072396 Endothelin-Converting Enzymes Metalloendopeptidases which convert BIG ENDOTHELIN to ENDOTHELIN-1. ECE-1beta,Endothelin Converting Enzyme,Endothelin Converting Enzyme-1a,Endothelin-Converting Enzyme,Endothelin-Converting Enzyme 1,Endothelin-Converting Enzyme 2,Endothelin-Converting Enzyme II,Endothelin-Converting Enzyme-1b,Endothelin-Converting Metalloprotease 2,Metalloprotease ECE-2,ECE-2, Metalloprotease,Endothelin Converting Enzyme 1,Endothelin Converting Enzyme 1a,Endothelin Converting Enzyme 1b,Endothelin Converting Enzyme 2,Endothelin Converting Enzyme II,Endothelin Converting Enzymes,Endothelin Converting Metalloprotease 2,Metalloprotease ECE 2
D000860 Hypoxia Sub-optimal OXYGEN levels in the ambient air of living organisms. Anoxia,Oxygen Deficiency,Anoxemia,Deficiency, Oxygen,Hypoxemia,Deficiencies, Oxygen,Oxygen Deficiencies

Related Publications

S Granchi, and G B Vannelli, and L Vignozzi, and C Crescioli, and P Ferruzzi, and R Mancina, and M C Vinci, and G Forti, and S Filippi, and M Luconi, and F Ledda, and M Maggi
January 1998, Journal of cardiovascular pharmacology,
S Granchi, and G B Vannelli, and L Vignozzi, and C Crescioli, and P Ferruzzi, and R Mancina, and M C Vinci, and G Forti, and S Filippi, and M Luconi, and F Ledda, and M Maggi
May 2002, British journal of pharmacology,
S Granchi, and G B Vannelli, and L Vignozzi, and C Crescioli, and P Ferruzzi, and R Mancina, and M C Vinci, and G Forti, and S Filippi, and M Luconi, and F Ledda, and M Maggi
January 1995, Journal of cardiovascular pharmacology,
S Granchi, and G B Vannelli, and L Vignozzi, and C Crescioli, and P Ferruzzi, and R Mancina, and M C Vinci, and G Forti, and S Filippi, and M Luconi, and F Ledda, and M Maggi
January 1992, Japanese circulation journal,
S Granchi, and G B Vannelli, and L Vignozzi, and C Crescioli, and P Ferruzzi, and R Mancina, and M C Vinci, and G Forti, and S Filippi, and M Luconi, and F Ledda, and M Maggi
January 1995, Journal of cardiovascular pharmacology,
S Granchi, and G B Vannelli, and L Vignozzi, and C Crescioli, and P Ferruzzi, and R Mancina, and M C Vinci, and G Forti, and S Filippi, and M Luconi, and F Ledda, and M Maggi
October 1998, Journal of cardiovascular pharmacology,
S Granchi, and G B Vannelli, and L Vignozzi, and C Crescioli, and P Ferruzzi, and R Mancina, and M C Vinci, and G Forti, and S Filippi, and M Luconi, and F Ledda, and M Maggi
May 2021, Microorganisms,
S Granchi, and G B Vannelli, and L Vignozzi, and C Crescioli, and P Ferruzzi, and R Mancina, and M C Vinci, and G Forti, and S Filippi, and M Luconi, and F Ledda, and M Maggi
January 1989, Journal of cardiovascular pharmacology,
S Granchi, and G B Vannelli, and L Vignozzi, and C Crescioli, and P Ferruzzi, and R Mancina, and M C Vinci, and G Forti, and S Filippi, and M Luconi, and F Ledda, and M Maggi
November 2000, Journal of cardiovascular pharmacology,
S Granchi, and G B Vannelli, and L Vignozzi, and C Crescioli, and P Ferruzzi, and R Mancina, and M C Vinci, and G Forti, and S Filippi, and M Luconi, and F Ledda, and M Maggi
November 1995, British journal of pharmacology,
Copied contents to your clipboard!